BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11664138)

  • 1. Report urges freedom for genetic engineers.
    New Sci; 1981 Apr; 90(1247):8. PubMed ID: 11664138
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflicts of interest.
    Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
    [No Abstract]   [Full Text] [Related]  

  • 3. Business and the academy.
    Bok DC
    Harv Mag; 1981; 83(5):23-35. PubMed ID: 11662883
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA: have the corporations already grabbed control of new life forms?
    Rifkin J
    Mother Jones; 1977; 2(2):23-39. PubMed ID: 11649384
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical and legal issues in patenting new animal life.
    Dresser R
    Jurimetrics; 1988; 28(4):399-435. PubMed ID: 11652544
    [No Abstract]   [Full Text] [Related]  

  • 6. Draft report to annual and central conferences, Dec 1990: an invitation to explore a frontier.
    United Methodist Church. Genetic Science Task Force
    Engage Soc Action; 1991 Jan; 4(1):17-27. PubMed ID: 11659313
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant DNA: a case study in regulation of scientific research.
    Chalfant JC; Hartmann ME; Blakeboro A
    Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069
    [No Abstract]   [Full Text] [Related]  

  • 8. Patenting of life forms.
    Pautler G
    Trial; 1982 Apr; 18(4):47-50, 76. PubMed ID: 11649513
    [No Abstract]   [Full Text] [Related]  

  • 9. Patenting biology: DNA and oil-eaters.
    Sci News; 1978 Mar; 113(11):167+. PubMed ID: 11661560
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic engineering and related biotechnologies: scientific progress and public policy.
    Perpich JG
    Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposals on genetic technology: U.S. panel urges easing of regulation.
    Andrews EL
    N Y Times Web; 1991 Feb; ():D1, D7. PubMed ID: 11646818
    [No Abstract]   [Full Text] [Related]  

  • 12. The regulation of genetic engineering.
    Breyer S; Zeckhauser R
    Man Med; 1975; 1(1):1-12. PubMed ID: 12083123
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the Human Genome Project at the interface between patent and FDA laws.
    Cunningham BC
    Risk; 1996; 7(3):253-66. PubMed ID: 11655078
    [No Abstract]   [Full Text] [Related]  

  • 14. OTA: no new laws are needed to regulate certain gene therapies.
    Krieger L
    Am Med News; 1984 Dec; 27(48):2, 19. PubMed ID: 11653610
    [No Abstract]   [Full Text] [Related]  

  • 15. The status of recombinant DNA research.
    Stevenson AE
    Congr Rec (Dly Ed); 1978 Oct; 124(168):S19351-7. PubMed ID: 11661781
    [No Abstract]   [Full Text] [Related]  

  • 16. A commercial debut for DNA technology.
    Bus Week; 1977 Dec; (2513):. PubMed ID: 11661586
    [No Abstract]   [Full Text] [Related]  

  • 17. President's Commission urges changes in proposed regulations.
    IRB; 1980 Nov; 2(9):9. PubMed ID: 11661888
    [No Abstract]   [Full Text] [Related]  

  • 18. US genetic engineers cut through red tape.
    New Sci; 1981 Jan; 89(1237):198. PubMed ID: 11664091
    [No Abstract]   [Full Text] [Related]  

  • 19. Innocuous inoculum or perilous parasite? Encouraging genetic research through patent grants: a call for regulation and debate.
    Brashear JF
    San Diego Law Rev; 1981 Mar; 18(2):263-99. PubMed ID: 11650644
    [No Abstract]   [Full Text] [Related]  

  • 20. The great 'recombinant DNA' controversy and the need for public debate.
    Pearson M
    Sci Forum; 1977 Jun; 10(3):3-4+. PubMed ID: 11650574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.